ReviewBMJ (Clinical research ed.)2006
Review of NICE's recommendations, 1999-2005.
Review in BMJ (Clinical research ed.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review of whole disease models for informing healthcare resource allocation decisions.PloS one · 2023Pooled it
- Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Pooled it
- Trial
- Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2008Trial
- Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study.Risk management and healthcare policy · 2020Article
- Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.Journal of managed care & specialty pharmacy · 2017Article
- Article
- Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme.The European journal of health economics : HEPAC : health economics in prevention and care · 2014Article
- The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients.BMC ophthalmology · 2014Article
- Health economics and health technology assessment in Central and Eastern Europe: a dose of reality.The European journal of health economics : HEPAC : health economics in prevention and care · 2012Article
- Article
- Biosimilar medicines and cost-effectiveness.ClinicoEconomics and outcomes research : CEOR · 2011Article
- Valorising and creating access to innovative medicines in the European union.Frontiers in pharmacology · 2011Article
- Use of economic evaluation in decision making: evidence and recommendations for improvement.Drugs · 2010Article
- How to assess the value of medicines?Frontiers in pharmacology · 2010Article
- Access with evidence development in the UK: past experience, current initiatives and future potential.PharmacoEconomics · 2010Article
- Health economic assessment: a methodological primer.International journal of environmental research and public health · 2009Review
- Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2009Article
- From rationing to rational: the evolving status of NICE.Journal of the Royal Society of Medicine · 2008Article
- Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Health and quality of life outcomes · 2008Article
Corrections and comments
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.